Nationwide, CRESTOR® (rosuvastatin calcium) is gaining preferred formulary access faster than Lipitor® or Vytorin® — preferred formulary access can reduce obstacles for you and your patients with prescription drug coverage.* CRESTOR is covered on more than 84% of formulary plans nationwide without prior authorization.†
*Based on changes in Tier 1 & 2 coverage status, 6/08-3/09. Data on File, CRESTOR Preferred Access Growth: Fingertip Formulary® Database (last accessed March 24, 2009).
†From Fingertip Formulary as of June 2009. Defined as covered without prior authorization on commercial, Medicare Part D,
and Medicaid formularies. Patients without prior authorization means covered lives at Tiers 1 to 7 calculated by
Fingertip Formulary® as of July 2008 that do not require additional information to the health plan in order for
CRESTOR to be covered. Data include covered lives whose prescriptions may be subject to step-therapy
requirements.
The CRESTOR Formulary Database is a simple-to-use tool that allows you to determine CRESTOR coverage for health plans specific to your area. Simply select your state and up to six health plans. Your results will show available coverage and any restrictions that may apply.
If you’re considering prescribing CRESTOR to your at-risk patients, find out how you can make it even easier for them to afford their medication with our money-saving offers.
Lipitor is a registered trademark of Pfizer Inc.
Vytorin is a registered trademark of MSP Singapore Company, LLC.
This information is provided for general purposes only and is not an
endorsement of any particular health plan as of
November 2009. Individual plans may vary and all information is
subject to change. For the most current formulary information, contact your
patient's drug benefit provider.
The following definitions are generally applicable though they may vary by
plan. Please contact your patient's plan for specific information regarding
his or her tier structure.
N/A
Not applicable.
Not Covered
Drugs that are not covered by the plan.
Patient pays the difference
Patient pays the difference means that the plan requires that the patient pay the difference in cost between the brand product and the generic product.
Tier 1
This drug is available at the lowest co-pay. Most commonly, these are generic drugs.
Tier 2
This drug is available at a middle level co-pay. Most commonly, these are "preferred" (on formulary) brand drugs.
Tier 3
This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" (off formulary) brand drugs.
|
|
Tier 4
This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" (off formulary) brand drugs or specialty prescription products.
Tier 5
This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" (off formulary) brand drugs or specialty prescription products.
Tier 6
This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" (off formulary) brand drugs or specialty prescription products.
Tier 7
This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" (off formulary) brand drugs or specialty prescription products.
|
OR (Other Restrictions)
Drugs with additional restrictions. An example is limitations that apply to certain strengths.
PA (Prior Authorization)
Drugs that require prior authorization. Typically, your doctor must provide additional information to your health plan in order for these drugs to be covered.
QL (Quantity Limits)
Drugs that have quantity limits with each prescription.
|
|
ST (Step Therapy)
Drugs that include step therapy. Typically, your doctor must provide additional information to your health plan in order for these drugs to be covered.
|
